1.14.14.3 1,4-benzoquinone - 315 1.14.14.3 1-aminodecanal - 194304 1.14.14.3 1-aminododecanal - 194305 1.14.14.3 1-Decanol - 3959 1.14.14.3 1-Dodecanol - 5887 1.14.14.3 1-Heptanol - 2632 1.14.14.3 1-nonanol - 4638 1.14.14.3 1-Octanol - 1228 1.14.14.3 1-Tetradecanol - 5458 1.14.14.3 1-undecanol - 52177 1.14.14.3 2,2-diphenylpropylamine - 194303 1.14.14.3 2,3-Dichloro-(6-phenylphenoxy)ethylamine - 29328 1.14.14.3 2,4-dinitrofluorobenzene i.e. Sanger's reagent 7981 1.14.14.3 2-Bromodecanal protection by dithiothreitol or mercaptoethanol 90984 1.14.14.3 2-diethylaminoethyl-2,2-diphenylvalerate - 29380 1.14.14.3 2-methyl-1,4-benzoquinone - 4102 1.14.14.3 2-methyl-5-isopropyl-1,4-benzoquinone - 155125 1.14.14.3 5-decyl-4a-hydroxy-4a,5-dihydroriboflavin-5'-phosphate binding and fluorescence quantum yield studies of the substance as a model, complexed with the enzyme in a 1:1 molcular ratio leading to 80% and 90% inhibition of wild-type and mutant C106A at 0.01 mM, respectively, binds to the active site 124964 1.14.14.3 6-(3'-(R)-myristyl) flavin adenine mononucleotide binds noncovalently to the enzyme dimer. Addition of recombinant apo-LuxF captures myrFMN and thereby relieves the inhibitory effect 224431 1.14.14.3 8-Anilino-1-naphthalenesulfonate - 12404 1.14.14.3 8-Anilino-1-naphthalenesulfonate inhibitor binding site separate from FMN-binding site by 30 A 12404 1.14.14.3 acetone - 333 1.14.14.3 aliphatic alcohols - 16060 1.14.14.3 Aliphatic alkanes - 98379 1.14.14.3 amino group reagents - 20992 1.14.14.3 benzylalcohol - 4228 1.14.14.3 Butanone - 3620 1.14.14.3 chloroform - 4509 1.14.14.3 CN- - 159 1.14.14.3 Decanoic acid - 2551 1.14.14.3 diethylether - 21393 1.14.14.3 dodecanamide inhibits bacterial luciferase luminescence reaction. By injecting the dodecaneamide into the bacterial luciferase system, the luminescence intensity decreases to about half of the initial intensity 155124 1.14.14.3 dodecanenitrile - 194302 1.14.14.3 dodecanoic acid - 2019 1.14.14.3 Dodecanol - 3632 1.14.14.3 dodecylamine - 11199 1.14.14.3 Enflurane - 93320 1.14.14.3 ethoxyformic anhydride - 9161 1.14.14.3 FADH2 - 256 1.14.14.3 Fluroxene - 93398 1.14.14.3 fullerenol fullerenols suppress bioluminescent intensity at concentrations above 0.01 g/l and above 0.001 g/l for C60O2-4(OH)20-24 and Fe0.5C60(OH)xOy, respectively 224432 1.14.14.3 Halothane - 15777 1.14.14.3 imidazole reagents - 31040 1.14.14.3 iodoacetamide - 67 1.14.14.3 Isoflurane - 93721 1.14.14.3 lumichrome - 2853 1.14.14.3 Lumiflavin - 5990 1.14.14.3 methanol bacterial luciferase luminescence intensity decreases to the steady state depending on the methanol concentration 83 1.14.14.3 Methoxyflurane - 44414 1.14.14.3 additional information luxA mutant and luxB mutant strains are more sensitive to oxidants like H2O2, cumene hydroperoxide, tert-butyl hydroperoxide, or ferrous sulfate, than the wild-type strain, growth behaviour overview 2 1.14.14.3 additional information increases in oxygen concentration lead to gradual decreases of the peak bioluminescence intensity, Km for FMN, and Km for NADPH of NADPH-specific flavin reductase in the coupled reaction with luciferase 2 1.14.14.3 additional information hydrophobicity of the quinone plays a role in the non-specific inhibition mechanism of xenobiotic molecules in the bacterial bioluminescence system via altering the rotational mobility of the endogenous flavin in the luciferase. Added quinone reduces the averaged binding affinity of the endogenous FMN to the active site of luciferase by increasing the fraction of the weak FMN binding sites of luciferase 2 1.14.14.3 additional information 1-hexanol does not inhibit the enzyme luminescence 2 1.14.14.3 N,N-Diethyl-2,4-dichloro-(6-phenylphenoxy)ethylamine - 94114 1.14.14.3 N,N-Dimethylaniline - 15852 1.14.14.3 n-decanal reversible substrate inhibition, depending on phosphate concentration 5580 1.14.14.3 n-decanal - 5580 1.14.14.3 N-ethylmaleimide protection by substrates 49 1.14.14.3 N-phenacylthiazolium bromide highly selective inhibition 194301 1.14.14.3 nonal - 106879 1.14.14.3 Paraldehyde - 94656 1.14.14.3 Pargyline - 1761 1.14.14.3 pifithrin-alpha highly selective inhibitor in vivo and in vitro 59029 1.14.14.3 potassium iodide quenches the fluorescence of FMN effectively at 0.2 M, and enhances the decay of wild-type and HFOOH enzymes, the wild-type enzyme forms an inactive complex with KI 22478 1.14.14.3 Proteases trypsin, chymotrypsin 2772 1.14.14.3 reduced riboflavin - 4863 1.14.14.3 SKF-525A - 21407 1.14.14.3 sulfhydryl reagents - 978 1.14.14.3 trans-2-decenal - 13091 1.14.14.3 Tridecanoic acid - 30483 1.14.14.3 Undecanal - 5630 1.14.14.3 undecane - 13362 1.14.14.3 Uracil - 334 1.14.14.3 Urea denaturation curve, thermodynamics, wild-type and mutants, overview 116 1.14.14.3 urethane - 4058